HSA approves molnupiravir
Singapore OKs molnupiravir for COVID-19 treatment
The drug is the second oral antiviral medicine authorised for COVID-19 treatment.
Singapore OKs molnupiravir for COVID-19 treatment
The drug is the second oral antiviral medicine authorised for COVID-19 treatment.
Resource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Events
Apr
09
Event News
Event News
Highlight your innovative medical initiatives at Healthcare Asia Awards, Medtech Awards, Pharma Awards 2025Â
![Highlight your innovative medical initiatives at Healthcare Asia Awards, Medtech Awards, Pharma Awards 2025Â]()
Co-Written / Partner
The awards programmes honour outstanding leaders and companies in the healthcare industry across Asia.
The awards programmes honour outstanding leaders and companies in the healthcare industry across Asia.
Videos
Partner Sites
Awards
Apr
10
Events
Apr
09